SBI Securities’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.95K Sell
59
-14
-19% -$1.96K ﹤0.01% 1892
2025
Q4
$12K Buy
73
+1
+1% +$157 ﹤0.01% 1651
2025
Q3
$9.62K Sell
72
-25
-26% -$3.04K ﹤0.01% 1788
2025
Q2
$12.1K Hold
97
﹤0.01% 1624
2025
Q1
$12.3K Hold
97
﹤0.01% 1519
2024
Q4
$14K Buy
+97
New +$13.9K ﹤0.01% 1501

Other funds holding RGEN

SBI Securities's RGEN Position: Q1 2026 in Review

SBI Securities reduced its Repligen (RGEN) stake by 19% in Q1 2026, selling an estimated $1.96K and leaving 59 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #1892.

SBI Securities first reported a position in RGEN in Q4 2024 and has held it in 6 quarters since. The position peaked at $14K in Q4 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • SBI Securities held 59 shares of Repligen worth $6.95K as of Q1 2026.
  • SBI Securities sold 14 Repligen shares in Q1 2026, an estimated $1.96K.
  • Repligen made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1892 holding.
  • SBI Securities first reported a position in Repligen in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Repligen position peaked at $14K in Q4 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.